Announcement: SOA congratulates the new ASAs and CERAs for November 2025.

1 - 5 of 5 results (0.27 seconds)
Sort By:
  • Climate Risk Analysis for Life and Health Insurance Companies

    Climate Risk Analysis for Life and Health Insurance Companies On March 31, 2022, the SOA Research Institute assembled an expert panel to discuss key considerations related to climate risk ...

    View Description

    • Authors: Didier Serre
    • Date: Jun 2022
    • Competency: External Forces & Industry Knowledge
    • Topics: Actuarial Profession; Environment
  • Evaluating Payment Models for High-Cost Curative Therapies

    Evaluating Payment Models for High-Cost Curative Therapies This report evaluates alternative payment models that potentially could be instituted by healthcare payers and manufacturers. Health ...

    View Description

    • Authors: Didier Serre, Joanne L Buckle, Jessica Marie Naber, Anne M Jackson
    • Date: Oct 2018
    • Competency: External Forces & Industry Knowledge
    • Topics: Health & Disability>Health care; Health & Disability>Payment models
  • New Report on Evaluating Payment Models for High-Cost Curative Therapies

    New Report on Evaluating Payment Models for High-Cost Curative Therapies This short article presents the latest SOA health research report on alternative payment models for high-cost curative ...

    View Description

    • Authors: Didier Serre
    • Date: Mar 2019
    • Competency: Technical Skills & Analytical Problem Solving>Innovative solutions
    • Publication Name: Health Watch
    • Topics: Health & Disability>Payment models
  • Climate Risk Analysis for Life and Health Insurance Companies

    Climate Risk Analysis for Life and Health Insurance Companies On March 31, 2022, the SOA Research Institute assembled an expert panel to discuss key considerations related to climate risk ...

    View Description

    • Authors: Didier Serre
    • Date: Jun 2022
    • Competency: External Forces & Industry Knowledge
    • Topics: Actuarial Profession; Environment
  • Genomic Testing: Cost-Saving or Cost-Inflating for Payers?

    Genomic Testing: Cost-Saving or Cost-Inflating for Payers? As private payers ponders the early adoption of genomic testing to guide treatment pathways, can personalized approaches to care prove ...

    View Description

    • Authors: Didier Serre
    • Date: Feb 2018
    • Competency: External Forces & Industry Knowledge>Actuarial methods in business operations; Results-Oriented Solutions>Assess decision effectiveness
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care